Dr. Daniel Sterman is an Associate Professor in Medicine, an Associate Professor of Medicine in Surgery, Director of Interventional Pulmonology and Clinical Director of Thoracic Oncology Gene Therapy Program at the University of Pennsylvania Medical Center, Pulmonary, Allergy and Critical Care Division in Philadelphia, PA.
He received his MD in 1989 after graduated the Cornell University Medical College. He continued with his Internship and Residency in Internal Medicine at the Hospital of the University of Pennsylvania, until 1992.
Later, he also completed an instructorship at the Emergency Medicine, and his fellowship training was on Pulmonary and Critical Care Medicine, at the University of Pennsylvania. He also received a fellowship in Interventional Bronchoscopy and Pleuroscopy at the Pennsylvania Hospital.
Moreover, Dr. Daniel Sterman has advanced training in flexible and rigid bronchoscopy, balloon branchoplasty, endobronchial stent placemant, endobronchial brachytherapy, photodynamic therapy, etc. He is very interested in malignancies, treatment of thoracic maliganancies and novel technologies in interventional pulmonology.
Dr. Sterman is conducting various human clinical trials of gene therapy and vaccine therapy for lung cancer, mesothelioma cancer and other pleural malignancies. He is board certified in Internal Medicine, Pulmonary Medicine and Critical Care Medicine and he was involved in various pioneering clinical research projects.
Contact mesothelioma doctors today and start with the right treatment!
Mesothelioma (cancer of the mesothelium) is a disease in which cells of the mesothelium become abnormal and divide without control or order. They can invade and damage nearby tissues and organs. Cancer cells can also metastasize (spread) from their original site to other parts of the body. Most cases of mesothelioma begin in the pleura or peritoneum.
Test Test